0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
STD Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-38W5892
Home | Market Reports | Health| Reproductive Health
Global STD Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

STD Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-38W5892
Report
September 2024
Pages:159
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

STD Diagnostics - Market Size

The global market for STD Diagnostics was estimated to be worth US$ 184080 million in 2023 and is forecast to a readjusted size of US$ 296290 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030

STD Diagnostics - Market

STD Diagnostics - Market

STD Diagnostics is the procedure to test if the patient have the STD.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for STD Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of STD Diagnostics by region & country, by Type, and by Application.
The STD Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding STD Diagnostics.
Market Segmentation

Scope of STD Diagnostics - Market Report

Report Metric Details
Report Name STD Diagnostics - Market
Forecasted market size in 2030 US$ 296290 million
CAGR 6.9%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Laboratory Testing
  • Point of Care Testing
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of STD Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of STD Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of STD Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the STD Diagnostics - Market size in 2030?

Ans: The STD Diagnostics - Market size in 2030 will be US$ 296290 million.

Who are the main players in the STD Diagnostics - Market report?

Ans: The main players in the STD Diagnostics - Market are Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere

What are the Application segmentation covered in the STD Diagnostics - Market report?

Ans: The Applications covered in the STD Diagnostics - Market report are Laboratory Testing, Point of Care Testing

What are the Type segmentation covered in the STD Diagnostics - Market report?

Ans: The Types covered in the STD Diagnostics - Market report are Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing

Recommended Reports

Infectious Disease Diagnostics

Diagnostics Devices & Systems

Specialty & Cancer Diagnostics

1 Market Overview
1.1 STD Diagnostics Product Introduction
1.2 Global STD Diagnostics Market Size Forecast
1.3 STD Diagnostics Market Trends & Drivers
1.3.1 STD Diagnostics Industry Trends
1.3.2 STD Diagnostics Market Drivers & Opportunity
1.3.3 STD Diagnostics Market Challenges
1.3.4 STD Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global STD Diagnostics Players Revenue Ranking (2023)
2.2 Global STD Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies STD Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies STD Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of STD Diagnostics
2.6 STD Diagnostics Market Competitive Analysis
2.6.1 STD Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by STD Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chlamydia Testing
3.1.2 Syphilis Testing
3.1.3 Gonorrhea Testing
3.1.4 Herpes Simplex Virus Testing
3.1.5 Human Papilloma Virus Testing
3.1.6 Human Immunodeficiency Virus Testing
3.1.7 Chancroid Testing
3.2 Global STD Diagnostics Sales Value by Type
3.2.1 Global STD Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global STD Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global STD Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory Testing
4.1.2 Point of Care Testing
4.2 Global STD Diagnostics Sales Value by Application
4.2.1 Global STD Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global STD Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global STD Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global STD Diagnostics Sales Value by Region
5.1.1 Global STD Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global STD Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global STD Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global STD Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America STD Diagnostics Sales Value, 2019-2030
5.2.2 North America STD Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe STD Diagnostics Sales Value, 2019-2030
5.3.2 Europe STD Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific STD Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific STD Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America STD Diagnostics Sales Value, 2019-2030
5.5.2 South America STD Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa STD Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa STD Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions STD Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions STD Diagnostics Sales Value
6.3 United States
6.3.1 United States STD Diagnostics Sales Value, 2019-2030
6.3.2 United States STD Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States STD Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe STD Diagnostics Sales Value, 2019-2030
6.4.2 Europe STD Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe STD Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China STD Diagnostics Sales Value, 2019-2030
6.5.2 China STD Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China STD Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan STD Diagnostics Sales Value, 2019-2030
6.6.2 Japan STD Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan STD Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea STD Diagnostics Sales Value, 2019-2030
6.7.2 South Korea STD Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea STD Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia STD Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia STD Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia STD Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India STD Diagnostics Sales Value, 2019-2030
6.9.2 India STD Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India STD Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott STD Diagnostics Products, Services and Solutions
7.1.4 Abbott STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Recent Developments
7.2 ADI/American Diagnostica
7.2.1 ADI/American Diagnostica Profile
7.2.2 ADI/American Diagnostica Main Business
7.2.3 ADI/American Diagnostica STD Diagnostics Products, Services and Solutions
7.2.4 ADI/American Diagnostica STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 ADI/American Diagnostica Recent Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Profile
7.3.2 Agilent Technologies Main Business
7.3.3 Agilent Technologies STD Diagnostics Products, Services and Solutions
7.3.4 Agilent Technologies STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Alere/Biosite/Inverness Recent Developments
7.4 Alere/Biosite/Inverness
7.4.1 Alere/Biosite/Inverness Profile
7.4.2 Alere/Biosite/Inverness Main Business
7.4.3 Alere/Biosite/Inverness STD Diagnostics Products, Services and Solutions
7.4.4 Alere/Biosite/Inverness STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Alere/Biosite/Inverness Recent Developments
7.5 Axis-Shield
7.5.1 Axis-Shield Profile
7.5.2 Axis-Shield Main Business
7.5.3 Axis-Shield STD Diagnostics Products, Services and Solutions
7.5.4 Axis-Shield STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Axis-Shield Recent Developments
7.6 Beckman Coulter/Danaher
7.6.1 Beckman Coulter/Danaher Profile
7.6.2 Beckman Coulter/Danaher Main Business
7.6.3 Beckman Coulter/Danaher STD Diagnostics Products, Services and Solutions
7.6.4 Beckman Coulter/Danaher STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Beckman Coulter/Danaher Recent Developments
7.7 Becton Dickinson
7.7.1 Becton Dickinson Profile
7.7.2 Becton Dickinson Main Business
7.7.3 Becton Dickinson STD Diagnostics Products, Services and Solutions
7.7.4 Becton Dickinson STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Becton Dickinson Recent Developments
7.8 Bio/Data
7.8.1 Bio/Data Profile
7.8.2 Bio/Data Main Business
7.8.3 Bio/Data STD Diagnostics Products, Services and Solutions
7.8.4 Bio/Data STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Bio/Data Recent Developments
7.9 Decode Genetics
7.9.1 Decode Genetics Profile
7.9.2 Decode Genetics Main Business
7.9.3 Decode Genetics STD Diagnostics Products, Services and Solutions
7.9.4 Decode Genetics STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Decode Genetics Recent Developments
7.10 Diadexus
7.10.1 Diadexus Profile
7.10.2 Diadexus Main Business
7.10.3 Diadexus STD Diagnostics Products, Services and Solutions
7.10.4 Diadexus STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Diadexus Recent Developments
7.11 Diagnocure
7.11.1 Diagnocure Profile
7.11.2 Diagnocure Main Business
7.11.3 Diagnocure STD Diagnostics Products, Services and Solutions
7.11.4 Diagnocure STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 Diagnocure Recent Developments
7.12 Diagnostica Stago/Trinity Biotech
7.12.1 Diagnostica Stago/Trinity Biotech Profile
7.12.2 Diagnostica Stago/Trinity Biotech Main Business
7.12.3 Diagnostica Stago/Trinity Biotech STD Diagnostics Products, Services and Solutions
7.12.4 Diagnostica Stago/Trinity Biotech STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Diagnostica Stago/Trinity Biotech Recent Developments
7.13 Diamedix
7.13.1 Diamedix Profile
7.13.2 Diamedix Main Business
7.13.3 Diamedix STD Diagnostics Products, Services and Solutions
7.13.4 Diamedix STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 Diamedix Recent Developments
7.14 Polymedco
7.14.1 Polymedco Profile
7.14.2 Polymedco Main Business
7.14.3 Polymedco STD Diagnostics Products, Services and Solutions
7.14.4 Polymedco STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.14.5 Polymedco Recent Developments
7.15 Qiagen
7.15.1 Qiagen Profile
7.15.2 Qiagen Main Business
7.15.3 Qiagen STD Diagnostics Products, Services and Solutions
7.15.4 Qiagen STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.15.5 Qiagen Recent Developments
7.16 Roche
7.16.1 Roche Profile
7.16.2 Roche Main Business
7.16.3 Roche STD Diagnostics Products, Services and Solutions
7.16.4 Roche STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.16.5 Roche Recent Developments
7.17 SDIX
7.17.1 SDIX Profile
7.17.2 SDIX Main Business
7.17.3 SDIX STD Diagnostics Products, Services and Solutions
7.17.4 SDIX STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.17.5 SDIX Recent Developments
7.18 Sequenom
7.18.1 Sequenom Profile
7.18.2 Sequenom Main Business
7.18.3 Sequenom STD Diagnostics Products, Services and Solutions
7.18.4 Sequenom STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.18.5 Sequenom Recent Developments
7.19 Siemens
7.19.1 Siemens Profile
7.19.2 Siemens Main Business
7.19.3 Siemens STD Diagnostics Products, Services and Solutions
7.19.4 Siemens STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.19.5 Siemens Recent Developments
7.20 Sienco
7.20.1 Sienco Profile
7.20.2 Sienco Main Business
7.20.3 Sienco STD Diagnostics Products, Services and Solutions
7.20.4 Sienco STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.20.5 Sienco Recent Developments
7.21 Sysmex
7.21.1 Sysmex Profile
7.21.2 Sysmex Main Business
7.21.3 Sysmex STD Diagnostics Products, Services and Solutions
7.21.4 Sysmex STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.21.5 Sysmex Recent Developments
7.22 Takara Bio
7.22.1 Takara Bio Profile
7.22.2 Takara Bio Main Business
7.22.3 Takara Bio STD Diagnostics Products, Services and Solutions
7.22.4 Takara Bio STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.22.5 Takara Bio Recent Developments
7.23 ThermoFisher
7.23.1 ThermoFisher Profile
7.23.2 ThermoFisher Main Business
7.23.3 ThermoFisher STD Diagnostics Products, Services and Solutions
7.23.4 ThermoFisher STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.23.5 ThermoFisher Recent Developments
7.24 Tosoh
7.24.1 Tosoh Profile
7.24.2 Tosoh Main Business
7.24.3 Tosoh STD Diagnostics Products, Services and Solutions
7.24.4 Tosoh STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.24.5 Tosoh Recent Developments
7.25 Wako
7.25.1 Wako Profile
7.25.2 Wako Main Business
7.25.3 Wako STD Diagnostics Products, Services and Solutions
7.25.4 Wako STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.25.5 Wako Recent Developments
7.26 Zycare/Alere
7.26.1 Zycare/Alere Profile
7.26.2 Zycare/Alere Main Business
7.26.3 Zycare/Alere STD Diagnostics Products, Services and Solutions
7.26.4 Zycare/Alere STD Diagnostics Revenue (US$ Million) & (2019-2024)
7.26.5 Zycare/Alere Recent Developments
8 Industry Chain Analysis
8.1 STD Diagnostics Industrial Chain
8.2 STD Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 STD Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 STD Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. STD Diagnostics Market Trends
    Table 2. STD Diagnostics Market Drivers & Opportunity
    Table 3. STD Diagnostics Market Challenges
    Table 4. STD Diagnostics Market Restraints
    Table 5. Global STD Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global STD Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies STD Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies STD Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of STD Diagnostics
    Table 10. Global STD Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global STD Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global STD Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global STD Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global STD Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global STD Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global STD Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global STD Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global STD Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global STD Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global STD Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global STD Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global STD Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global STD Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global STD Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global STD Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions STD Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions STD Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions STD Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Basic Information List
    Table 32. Abbott Description and Business Overview
    Table 33. Abbott STD Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in STD Diagnostics Business of Abbott (2019-2024)
    Table 35. Abbott Recent Developments
    Table 36. ADI/American Diagnostica Basic Information List
    Table 37. ADI/American Diagnostica Description and Business Overview
    Table 38. ADI/American Diagnostica STD Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in STD Diagnostics Business of ADI/American Diagnostica (2019-2024)
    Table 40. ADI/American Diagnostica Recent Developments
    Table 41. Agilent Technologies Basic Information List
    Table 42. Agilent Technologies Description and Business Overview
    Table 43. Agilent Technologies STD Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in STD Diagnostics Business of Agilent Technologies (2019-2024)
    Table 45. Agilent Technologies Recent Developments
    Table 46. Alere/Biosite/Inverness Basic Information List
    Table 47. Alere/Biosite/Inverness Description and Business Overview
    Table 48. Alere/Biosite/Inverness STD Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in STD Diagnostics Business of Alere/Biosite/Inverness (2019-2024)
    Table 50. Alere/Biosite/Inverness Recent Developments
    Table 51. Axis-Shield Basic Information List
    Table 52. Axis-Shield Description and Business Overview
    Table 53. Axis-Shield STD Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in STD Diagnostics Business of Axis-Shield (2019-2024)
    Table 55. Axis-Shield Recent Developments
    Table 56. Beckman Coulter/Danaher Basic Information List
    Table 57. Beckman Coulter/Danaher Description and Business Overview
    Table 58. Beckman Coulter/Danaher STD Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in STD Diagnostics Business of Beckman Coulter/Danaher (2019-2024)
    Table 60. Beckman Coulter/Danaher Recent Developments
    Table 61. Becton Dickinson Basic Information List
    Table 62. Becton Dickinson Description and Business Overview
    Table 63. Becton Dickinson STD Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in STD Diagnostics Business of Becton Dickinson (2019-2024)
    Table 65. Becton Dickinson Recent Developments
    Table 66. Bio/Data Basic Information List
    Table 67. Bio/Data Description and Business Overview
    Table 68. Bio/Data STD Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in STD Diagnostics Business of Bio/Data (2019-2024)
    Table 70. Bio/Data Recent Developments
    Table 71. Decode Genetics Basic Information List
    Table 72. Decode Genetics Description and Business Overview
    Table 73. Decode Genetics STD Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in STD Diagnostics Business of Decode Genetics (2019-2024)
    Table 75. Decode Genetics Recent Developments
    Table 76. Diadexus Basic Information List
    Table 77. Diadexus Description and Business Overview
    Table 78. Diadexus STD Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in STD Diagnostics Business of Diadexus (2019-2024)
    Table 80. Diadexus Recent Developments
    Table 81. Diagnocure Basic Information List
    Table 82. Diagnocure Description and Business Overview
    Table 83. Diagnocure STD Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in STD Diagnostics Business of Diagnocure (2019-2024)
    Table 85. Diagnocure Recent Developments
    Table 86. Diagnostica Stago/Trinity Biotech Basic Information List
    Table 87. Diagnostica Stago/Trinity Biotech Description and Business Overview
    Table 88. Diagnostica Stago/Trinity Biotech STD Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in STD Diagnostics Business of Diagnostica Stago/Trinity Biotech (2019-2024)
    Table 90. Diagnostica Stago/Trinity Biotech Recent Developments
    Table 91. Diamedix Basic Information List
    Table 92. Diamedix Description and Business Overview
    Table 93. Diamedix STD Diagnostics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in STD Diagnostics Business of Diamedix (2019-2024)
    Table 95. Diamedix Recent Developments
    Table 96. Polymedco Basic Information List
    Table 97. Polymedco Description and Business Overview
    Table 98. Polymedco STD Diagnostics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in STD Diagnostics Business of Polymedco (2019-2024)
    Table 100. Polymedco Recent Developments
    Table 101. Qiagen Basic Information List
    Table 102. Qiagen Description and Business Overview
    Table 103. Qiagen STD Diagnostics Products, Services and Solutions
    Table 104. Revenue (US$ Million) in STD Diagnostics Business of Qiagen (2019-2024)
    Table 105. Qiagen Recent Developments
    Table 106. Roche Basic Information List
    Table 107. Roche Description and Business Overview
    Table 108. Roche STD Diagnostics Products, Services and Solutions
    Table 109. Revenue (US$ Million) in STD Diagnostics Business of Roche (2019-2024)
    Table 110. Roche Recent Developments
    Table 111. SDIX Basic Information List
    Table 112. SDIX Description and Business Overview
    Table 113. SDIX STD Diagnostics Products, Services and Solutions
    Table 114. Revenue (US$ Million) in STD Diagnostics Business of SDIX (2019-2024)
    Table 115. SDIX Recent Developments
    Table 116. Sequenom Basic Information List
    Table 117. Sequenom Description and Business Overview
    Table 118. Sequenom STD Diagnostics Products, Services and Solutions
    Table 119. Revenue (US$ Million) in STD Diagnostics Business of Sequenom (2019-2024)
    Table 120. Sequenom Recent Developments
    Table 121. Siemens Basic Information List
    Table 122. Siemens Description and Business Overview
    Table 123. Siemens STD Diagnostics Products, Services and Solutions
    Table 124. Revenue (US$ Million) in STD Diagnostics Business of Siemens (2019-2024)
    Table 125. Siemens Recent Developments
    Table 126. Sienco Basic Information List
    Table 127. Sienco Description and Business Overview
    Table 128. Sienco STD Diagnostics Products, Services and Solutions
    Table 129. Revenue (US$ Million) in STD Diagnostics Business of Sienco (2019-2024)
    Table 130. Sienco Recent Developments
    Table 131. Sysmex Basic Information List
    Table 132. Sysmex Description and Business Overview
    Table 133. Sysmex STD Diagnostics Products, Services and Solutions
    Table 134. Revenue (US$ Million) in STD Diagnostics Business of Sysmex (2019-2024)
    Table 135. Sysmex Recent Developments
    Table 136. Takara Bio Basic Information List
    Table 137. Takara Bio Description and Business Overview
    Table 138. Takara Bio STD Diagnostics Products, Services and Solutions
    Table 139. Revenue (US$ Million) in STD Diagnostics Business of Takara Bio (2019-2024)
    Table 140. Takara Bio Recent Developments
    Table 141. ThermoFisher Basic Information List
    Table 142. ThermoFisher Description and Business Overview
    Table 143. ThermoFisher STD Diagnostics Products, Services and Solutions
    Table 144. Revenue (US$ Million) in STD Diagnostics Business of ThermoFisher (2019-2024)
    Table 145. ThermoFisher Recent Developments
    Table 146. Tosoh Basic Information List
    Table 147. Tosoh Description and Business Overview
    Table 148. Tosoh STD Diagnostics Products, Services and Solutions
    Table 149. Revenue (US$ Million) in STD Diagnostics Business of Tosoh (2019-2024)
    Table 150. Tosoh Recent Developments
    Table 151. Wako Basic Information List
    Table 152. Wako Description and Business Overview
    Table 153. Wako STD Diagnostics Products, Services and Solutions
    Table 154. Revenue (US$ Million) in STD Diagnostics Business of Wako (2019-2024)
    Table 155. Wako Recent Developments
    Table 156. Zycare/Alere Basic Information List
    Table 157. Zycare/Alere Description and Business Overview
    Table 158. Zycare/Alere STD Diagnostics Products, Services and Solutions
    Table 159. Revenue (US$ Million) in STD Diagnostics Business of Zycare/Alere (2019-2024)
    Table 160. Zycare/Alere Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. STD Diagnostics Downstream Customers
    Table 164. STD Diagnostics Distributors List
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
    Table 168. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. STD Diagnostics Product Picture
    Figure 2. Global STD Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global STD Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. STD Diagnostics Report Years Considered
    Figure 5. Global STD Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by STD Diagnostics Revenue in 2023
    Figure 7. STD Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Chlamydia Testing Picture
    Figure 9. Syphilis Testing Picture
    Figure 10. Gonorrhea Testing Picture
    Figure 11. Herpes Simplex Virus Testing Picture
    Figure 12. Human Papilloma Virus Testing Picture
    Figure 13. Human Immunodeficiency Virus Testing Picture
    Figure 14. Chancroid Testing Picture
    Figure 15. Global STD Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global STD Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Product Picture of Laboratory Testing
    Figure 18. Product Picture of Point of Care Testing
    Figure 19. Global STD Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global STD Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America STD Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America STD Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe STD Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe STD Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific STD Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific STD Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America STD Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America STD Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa STD Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa STD Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions STD Diagnostics Sales Value (%), (2019-2030)
    Figure 32. United States STD Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States STD Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States STD Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe STD Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe STD Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe STD Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. China STD Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China STD Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 40. China STD Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan STD Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan STD Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan STD Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea STD Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea STD Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea STD Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia STD Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia STD Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia STD Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. India STD Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India STD Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 52. India STD Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 53. STD Diagnostics Industrial Chain
    Figure 54. STD Diagnostics Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS